Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

Filing Details

Accession Number:
Form Type:
Zero Holdings:
Publication Time:
2019-05-02 16:30:28
Reporting Period:
Accepted Time:
2019-05-02 16:30:28
SEC Url:
Form 4 Filing
Cik Name Symbol Sector (SIC) IRS No
875045 Biogen Inc. BIIB Biological Products, (No Disgnostic Substances) (2836) 330112644
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1672709 Michel Vounatsos Biogen Inc.
225 Binney St.
Cambridge MA 02142
Chief Executive Officer Yes Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2019-05-01 4,351 $231.48 21,007 No 4 P Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Direct
  1. This represents the weighted average price for shares purchased at a range between $231.47 (low) and $232.06 (high).
  2. Full information regarding the number of shares purchased at each separate price will be provided to the SEC staff, the issuer or any security holder of the issuer, upon their request.
  3. Includes 82.051 shares acquired under the Biogen Inc. employee stock purchase plan on 3/29/2019.